Biopharma: The Competition for Talent, by the Numbers

To provide some data-driven insight into the fierce competition for senior biopharma executives, Catalyst Advisors analyzed 274 publicly held biopharma firms and the changes that occurred between January 2014 and March 2016 in four critical roles: chief executive officer, chief financial officer, chief medical officer and chief commercial officer. The study, included in Hunt Scanlon's 2016 State of the Search Industry Report, sheds light on turnover, internal promotion rates and the role of Big Pharma and biopharma M&A in replenishing the talent pool.